Global Information
회사소개 | 문의 | 비교리스트

세계의 갑상선암 진단 시장(2020-2027년) : 혈액검사, 영상 진단, 생검

Thyroid Cancer Diagnostics Market Size, Share & Trends Analysis Report By Technique (Blood Test, Imaging, Biopsy), By Type (Papillary Carcinoma, Follicular Carcinoma), By End Use, By Region, And Segment Forecasts, 2020 - 2027

리서치사 Grand View Research, Inc.
발행일 2020년 06월 상품 코드 943845
페이지 정보 영문 100 Pages
가격
US $ 5,950 ₩ 7,031,000 Unprintable PDF by E-mail (Single User License)
US $ 6,950 ₩ 8,213,000 Printable PDF by E-mail (5-User License)
US $ 8,950 ₩ 10,577,000 Printable PDF by E-mail (Enterprise License)


세계의 갑상선암 진단 시장(2020-2027년) : 혈액검사, 영상 진단, 생검 Thyroid Cancer Diagnostics Market Size, Share & Trends Analysis Report By Technique (Blood Test, Imaging, Biopsy), By Type (Papillary Carcinoma, Follicular Carcinoma), By End Use, By Region, And Segment Forecasts, 2020 - 2027
발행일 : 2020년 06월 페이지 정보 : 영문 100 Pages

세계의 갑상선암 진단 시장은 예측기간 중 5.5%의 CAGR로 확대되어 2027년에는 36억 달러 규모로 성장할 것으로 예측됩니다. 발증률 증가, 새로운 진단 제품 대두 등의 요인이 시장 성장을 추진하고 있습니다. 갑상선 결절은 세계 인구의 75.0% 이상 인구가 보유하고 있는 것으로 추정됩니다. 그러나 그 대부분은 무해하며 1.0% 미만이 악성입니다.

세계의 갑상선암 진단 시장을 조사했으며, 시장 및 제품 개요, 시장 성장에 대한 각종 영향요인 분석, 시장 규모·시장 점유율 예측, 종류·기술·최종사용자·지역 등 각종 세분화별 내역, 경쟁 상황, 주요 기업 개요 등을 정리했습니다.

제1장 조사 방법과 조사 범위

제2장 주요 요약

제3장 갑상선암 진단 시장 : 변수, 동향, 범위

  • 시장 전망
  • 보급률·성장률 전망
  • 규제 체계
  • 시장 역학
  • 시장 분석 툴

제4장 시장 분석과 예측 : 종류별

  • 정의·범위
  • 시장 점유율 실적과 예측
  • 대시보드
  • 시장 동향과 예측
  • 시장 규모와 예측
    • 유두암
    • 여포암
    • 기타

제5장 시장 분석과 예측 : 기술별

  • 정의·범위
  • 시장 점유율 실적과 예측
  • 대시보드
  • 시장 동향과 예측
  • 시장 규모와 예측
    • 혈액검사
    • 영상 진단
    • 생검
    • 기타

제6장 시장 분석과 예측 : 최종사용자별

  • 정의·범위
  • 시장 점유율 실적과 예측
  • 대시보드
  • 시장 동향과 예측
  • 시장 규모와 예측
    • 병원 실험실
    • 암 진단 센터
    • 연구기관
    • 기타

제7장 시장 분석과 예측 : 지역·주요 국가별

  • 현황
  • 주요 기업·시장 점유율
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • SWOT 분석
  • 시장 규모·시장 동향 예측

제8장 기업 개요

  • 주요 기업, 최근의 동향, 산업에 대한 영향
  • 주요 기업의 경쟁상 포지셔닝
  • 공개 기업
  • 비공개 기업
  • 기업 개요
KSM 20.07.10

List of Tables

  • TABLE 1 List of Abbreviation
  • TABLE 2 List of secondary sources
  • TABLE 3 North America thyroid cancer diagnostics market, by country, 2016 - 2027 (USD Million)
  • TABLE 4 North America thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 5 North America thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 6 North America thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 7 U.S. thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 8 U.S. thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 9 U.S. thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 10 Canada thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 11 Canada thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 12 Canada thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 13 Europe thyroid cancer diagnostics market, by country, 2016 - 2027 (USD Million)
  • TABLE 14 Europe thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 15 Europe thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 16 Europe thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 17 U.K. thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 18 U.K. thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 19 U.K. thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 20 Germany thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 21 Germany thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 22 Germany thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 23 France thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 24 France thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 25 France thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 26 Italy thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 27 Italy thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 28 Italy thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 29 Spain thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 30 Spain thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 31 Spain thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 32 Asia Pacific thyroid cancer diagnostics market, by country, 2016 - 2027 (USD Million)
  • TABLE 33 Asia Pacific thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 34 Asia Pacific thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 35 Asia Pacific thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 36 Japan thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 37 Japan thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 38 Japan thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 39 China thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 40 China thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 41 China thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 42 India thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 43 India thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 44 India thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 45 South Korea thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 46 South Korea thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 47 South Korea thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 48 Australia thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 49 Australia thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 50 Australia thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 51 Latin America thyroid cancer diagnostics market, by country, 2016 - 2027 (USD Million)
  • TABLE 52 Latin America thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 53 Latin America thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 54 Latin America thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 55 Brazil thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 56 Brazil thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 57 Brazil thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 58 Mexico thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 59 Mexico thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 60 Mexico thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 61 Argentina thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 62 Argentina thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 63 Argentina thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 64 MEA thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 65 MEA thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 66 MEA thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 67 South Africa thyroid cancer diagnostics market, by country, 2016 - 2027 (USD Million)
  • TABLE 68 South Africa thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 69 South Africa thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 70 South Africa thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 71 Saudi Arabia thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 72 Saudi Arabia thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 73 Saudi Arabia thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)
  • TABLE 74 UAE thyroid cancer diagnostics market, by type, 2016 - 2027 (USD Million)
  • TABLE 75 UAE thyroid cancer diagnostics market, by technique, 2016 - 2027 (USD Million)
  • TABLE 76 UAE thyroid cancer diagnostics market, by end use, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global thyroid cancer diagnostics market- Key market driver analysis
  • Fig. 7 Global thyroid cancer diagnostics market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global thyroid cancer diagnostics market - Porter's analysis
  • Fig. 10 Global thyroid cancer diagnostics market - PESTEL analysis
  • Fig. 11 Global thyroid cancer diagnostics market type outlook key takeaways
  • Fig. 12 Global thyroid cancer diagnostics market: Type movement analysis
  • Fig. 13 Papillary carcinoma market estimates, 2016 - 2027 (USD Million)
  • Fig. 14 Follicular carcinoma market estimates, 2016 - 2027 (USD Million)
  • FIG 16 Others market estimates, 2016 - 2027 (USD Million)
  • Fig. 17 Global thyroid cancer diagnostics market technique outlook key takeaways
  • Fig. 18 Global thyroid cancer diagnostics market: Technique movement analysis
  • Fig. 19 Blood test market estimates, 2016 - 2027 (USD Million)
  • Fig. 20 Imaging market estimates, 2016 - 2027 (USD Million)
  • Fig. 21 Biopsy market estimates, 2016 - 2027 (USD Million)
  • Fig. 22 Others market estimates, 2016 - 2027 (USD Million)
  • Fig. 23 Global thyroid cancer diagnostics market end-use outlook key takeaways
  • Fig. 24 Global thyroid cancer diagnostics market: End-use movement analysis
  • Fig. 25 Hospital laboratories market estimates, 2016 - 2027 (USD Million)
  • Fig. 26 Cancer diagnostics centers market estimates, 2016 - 2027 (USD Million)
  • Fig. 27 Research institutes market estimates, 2016 - 2027 (USD Million)
  • Fig. 28 Others market estimates, 2016 - 2027 (USD Million)
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 Global thyroid cancer diagnostics market: Regional movement analysis
  • Fig. 31 North America thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 32 U.S. thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 33 Canada thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 34 Europe thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 35 U.K. thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 36 Germany thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 37 France thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 38 Spain thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 39 Italy thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 40 Asia Pacific thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 41 Japan thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 42 China thyroid cancer diagnostics s market, 2016 - 2027 (USD Million)
  • Fig. 43 India thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 44 South Korea thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 45 Australia thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 46 Latin America thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • FIG 47 Brazil thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 48 Mexico thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 49 Argentina thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 50 MEA thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 51 South Africa thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 52 Saudi Arabia thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 53 UAE thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
  • Fig. 54 Strategy framework

Thyroid Cancer Diagnostics Market Growth & Trends

The global thyroid cancer diagnostics market size is expected to reach USD 3.6 billion by 2027, expanding at a CAGR of 5.5%, according to a new report by Grand View Research, Inc. The growth of the market is attributed to increasing disease prevalence and emergence of novel diagnostic products. Although the cancer is uncommon worldwide, the incidence rate is on the rise-driven by more sensitive and precise tools to diagnose the disease. It develops as a result of abnormal cell division in the thyroid gland. Since the glandular hormones regulate several functions-such as weight, body temperature, heart rate, and blood pressure, structural or functional anomalies are likely to affect several or all of the aforementioned factors.

It is estimated that over 75.0% of the global population has thyroid nodules; however, most of them are benign. Less than 1.0% of these nodules become malignant. Nearly 1.2% of all women and men are likely to be diagnosed with thyroid cancer in their lifetime. Although the disease can be manifested at any age group, the condition is most prevalent post 30 years of age. Furthermore, the disease aggressiveness escalates with age. Women are more susceptible to the disease than men.

Lack of exact signs and symptoms during the initial stages presents a challenge for early disease diagnosis. Advanced stages of the diseases are indicated by common symptoms, such as a lump in the neck, hoarseness of voice, pain in throat and neck, difficulty swallowing, and swollen lymph nodes in the neck. Although the exact causative factor remains unknown, thyroid cancer is largely associated with genetic mutations.

The market has undergone a paradigm shift over the last few years, driven by the introduction of biomarkers and launch of improved products for diagnosis. However, disease progression and recurrence remain high, especially among older patients. Strong unmet needs present a key opportunity to develop breakthrough first-in-class diagnosis of the disease.

Thyroid Cancer Diagnostics Market Report Highlights

  • Thyroid cancer is a relatively rare, accounting for 1 in 100 cases, in U.S
  • The condition affects women and men at 3:1 ratio
  • Papillary carcinoma accounts for nearly 80.0% of all cases
  • Imaging techniques, such as MRI, CT & PET scan, are the preferred tools for disease staging
  • Diagnostic tests at the molecular and genetic level are the prime growth drivers
  • In patients younger than 50 years, the cure rate for papillary and follicular carcinomas is nearly 98.0% - if treated appropriately
  • Asia Pacific is positioned to demonstrate the fastest regional growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources & third-party perspectives
    • 1.3.4. Primary research
  • 1.4. Information Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Thyroid Cancer Diagnostics Market Variables, Trends & Scope

  • 3.1. Thyroid Cancer Diagnostics Market Lineage outlook
    • 3.1.1. Parent market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Regulatory Framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing prevalence of thyroid cancer
      • 3.4.1.2. Novel product launches
      • 3.4.1.3. Technological advancements
      • 3.4.1.4. Increased consumer awareness
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High cost of diagnosis
      • 3.4.2.2. Adverse effeccts
  • 3.5. Thyroid Cancer Diagnostics Market Analysis Tools
    • 3.5.1. Industry analysis - Porter's
      • 3.5.1.1. Supplier Power: High due to large number of suppliers
      • 3.5.1.2. Buyer Power: Moderate due to technological advancements
      • 3.5.1.3. Substitution Threat: Moderate due to novel product launches
      • 3.5.1.4. Threat from New Entrant: Low due to stringent regulatory policies
      • 3.5.1.5. Competitive Rivalry: High due to increasing mergers & acquisitions by players
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political Landscape
      • 3.5.2.2. Environmental Landscape
      • 3.5.2.3. Social Landscape
      • 3.5.2.4. Technology Landscape
      • 3.5.2.5. Legal Landscape

Chapter 4. Thyroid Cancer Diagnostics Market: Type Estimates & Trend Analysis

  • 4.1. Definitions & Scope
  • 4.2. Type Market Share Analysis, 2019 & 2027
  • 4.3. Type Dashboard
  • 4.4. Global Thyroid Cancer Diagnostics Market, By Type, 2016 to 2027
  • 4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
    • 4.5.1. Papillary carcinoma
      • 4.5.1.1. Papillary carcinoma market, 2016 - 2027 (USD Million)
    • 4.5.2. Follicular carcinoma
      • 4.5.2.1. Follicular carcinoma market, 2016 - 2027 (USD Million)
    • 4.5.3. Others
      • 4.5.3.1. Others market, 2016 - 2027 (USD Million)

Chapter 5. Thyroid Cancer Diagnostics Market: Technique Estimates & Trend Analysis

  • 5.1. Definitions & Scope
  • 5.2. Technique Market Share Analysis, 2019 & 2027
  • 5.3. Technique Dashboard
  • 5.4. Global Thyroid Cancer Diagnostics Market, By Technique, 2016 to 2027
  • 5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
    • 5.5.1. Blood test
      • 5.5.1.1. Blood test market, 2016 - 2027 (USD Million)
    • 5.5.2. Imaging
      • 5.5.2.1. Imaging market, 2016 - 2027 (USD Million)
    • 5.5.3. Biopsy
      • 5.5.3.1. Biopsy market, 2016 - 2027 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others market, 2016 - 2027 (USD Million)

Chapter 6. Thyroid Cancer Diagnostics Market: End-use Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. End-use Market Share Analysis, 2019 & 2027
  • 6.3. End-use Dashboard
  • 6.4. Global Thyroid Cancer Diagnostics Market, By End Use, 2016 to 2027
  • 6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
    • 6.5.1. Hospital laboratories
      • 6.5.1.1. Hospital laboratories market, 2016 - 2027 (USD Million)
    • 6.5.2. Cancer diagnostic centers
      • 6.5.2.1. Cancer diagnostic centers, 2016 - 2027 (USD Million)
    • 6.5.3. Research institutes
      • 6.5.3.1. Research institutes, 2016 - 2027 (USD Million)
    • 6.5.4. Others
      • 6.5.4.1. Others, 2016 - 2027 (USD Million)

Chapter 7. Thyroid Cancer Diagnostics Market: Regional Estimates & Trend analysis

  • 7.1. Regional Market Snapshot
  • 7.2. Regional Market Share and Leading Players, 2019
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. Middle East & Africa
  • 7.3. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East & Africa
  • 7.4. Market Size, & Forecasts, and Trend Analysis, 2019 to 2027:
    • 7.4.1. North America
      • 7.4.1.1. North America thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.1.2. U.S.
      • 7.4.1.2.1. U.S. thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.1.3. Canada
      • 7.4.1.3.1. Canada thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
    • 7.4.2. Europe
      • 7.4.2.1. Europe thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.2.2. U.K.
      • 7.4.2.2.1. U.K. thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.2.3. Germany
      • 7.4.2.3.1. Germany thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.2.4. Spain
      • 7.4.2.4.1. Spain thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.2.5. France
      • 7.4.2.5.1. France thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.2.6. Italy
      • 7.4.2.6.1. Italy thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
    • 7.4.3. Asia Pacific
      • 7.4.3.1. Asia Pacific thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.3.2. China
      • 7.4.3.2.1. China thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.3.3. Japan
      • 7.4.3.3.1. Japan thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.3.4. India
      • 7.4.3.4.1. India thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.3.5. South Korea
      • 7.4.3.5.1. South Korea thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.3.6. Australia
      • 7.4.3.6.1. Australia thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
    • 7.4.4. Latin America
      • 7.4.4.1. Latin America thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.4.2. Brazil
      • 7.4.4.2.1. Brazil thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.4.3. Mexico
      • 7.4.4.3.1. Mexico thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.4.4. Argentina
      • 7.4.4.4.1. Argentina thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
    • 7.4.5. Middle East Africa
      • 7.4.5.1. MEA thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.5.2. South Africa
      • 7.4.5.2.1. South Africa thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.5.3. Saudi Arabia
      • 7.4.5.3.1. Saudi Arabia thyroid cancer diagnostics market, 2016 - 2027 (USD Million)
      • 7.4.5.4. UAE
      • 7.4.5.4.1. UAE thyroid cancer diagnostics market, 2016 - 2027 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Recent developments & impact analysis, by key market participants
  • 8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 8.3. Public Companies
    • 8.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 8.3.2. Competitive dashboard analysis
    • 8.3.3. Market differentiators
  • 8.4. Private Companies
  • 8.5. Company Profiles
    • 8.5.1. F. Hoffmann-La Roche Ltd.
      • 8.5.1.1. Company overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. Abbott
      • 8.5.2.1. Company overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Thermo Fisher Scientific, Inc.
      • 8.5.3.1. Company overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. General Electric
      • 8.5.4.1. Company overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Siemens Healthcare GmbH
      • 8.5.5.1. Company overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. Bio-Rad Laboratories, Inc.
      • 8.5.6.1. Company overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. Toshiba Corporation
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Koninklijke Philips N.V.
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Agilent Technologies, Inc.
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product benchmarking
      • 8.5.9.4. Strategic initiatives
Back to Top
전화 문의
F A Q